bf/NASDAQ:ORGO_icon.jpeg

COM:ORGANOGENESIS

Organogenesis Holdings Inc.

  • Stock

Last Close

3.50

12/11 21:00

Market Cap

379.16M

Beta: -

Volume Today

501.45K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
6.66M
-
18.12M
172.04%
25.36M
39.95%
26.41M
4.15%
24.90M
5.71%
26.52M
6.49%
average payables
9.58M
-
23.78M
148.12%
25.88M
8.87%
26.36M
1.84%
30.83M
16.97%
31.53M
2.25%
average receivables
17.04M
-
36.72M
115.50%
48.08M
30.95%
69.63M
44.82%
85.95M
23.44%
85.72M
0.27%
book value per share
4.75
-
4.67
1.76%
0.68
85.45%
0.60
11.78%
1.36
126.48%
1.89
39.10%
2.04
8.30%
0.00
99.90%
capex per share
-0.03
-
-0.07
150.65%
-0.20
192.29%
-0.24
23.95%
-0.26
7.13%
-0.00
99.93%
capex to depreciation
-0.27
-
-0.66
148.39%
-2.83
328.35%
-1.87
33.88%
-1.88
0.42%
-1.59
15.66%
capex to operating cash flow
0.03
-
0.19
508.16%
-3.11
1,772.15%
-0.50
83.80%
-1.36
170.70%
-0.79
42.21%
capex to revenue
-0.01
-
-0.02
148.84%
-0.06
161.67%
-0.07
6.71%
-0.08
12.71%
-0.06
25.18%
cash per share
0.02
-
0.00
88.03%
0.31
15,485.21%
0.65
111.02%
0.78
20.86%
0.89
13.33%
0.79
11.25%
0.00
99.90%
days of inventory on hand
70.66
-
110.14
55.87%
116.20
5.50%
79.97
31.18%
86.13
7.70%
96.85
12.44%
days payables outstanding
101.66
-
136.43
34.19%
97.73
28.36%
93.77
4.05%
112.36
19.83%
105.32
6.27%
days sales outstanding
64.30
-
55.05
14.39%
61.29
11.34%
64.30
4.92%
72.41
12.61%
69.10
4.57%
debt to assets
0.42
-
0.00
-
0.36
113,151.02%
0.46
25.91%
0.29
36.86%
0.30
3.69%
0.28
7.70%
0.13
53.75%
debt to equity
-1.08K
-
0.00
-
1.26
375,335.99%
1.81
43.68%
0.58
67.94%
0.55
5.80%
0.47
14.76%
0.21
54.86%
dividend yield
0.13
-
earnings yield
-0.00
-
-0.00
875.62%
-0.09
2,688.46%
-0.09
1.69%
0.02
124.42%
0.08
261.74%
0.04
44.53%
0.00
99.93%
enterprise value
48.94K
-
615.12M
1,256,840.59%
633.63M
3.01%
741.55M
17.03%
486.99M
34.33%
811.64M
66.66%
1.20B
48.36%
371.20M
69.17%
542.89B
146,151.64%
enterprise value over ebitda
-2.95K
-
-137.99
95.32%
-18.15
86.85%
-24.33
34.06%
23.20
195.36%
13.44
42.07%
9.21
31.51%
43.34K
470,731.01%
ev to operating cash flow
-1.09K
-
-1.08K
1.27%
-12.21
98.87%
-14.53
18.97%
119.34
921.63%
19.43
83.72%
14.93
23.14%
17.56K
117,494.51%
ev to sales
3.83
-
1.87
51.32%
2.40
28.57%
2.57
7.23%
0.82
68.00%
1.25K
152,146.01%
free cash flow per share
-0.01
-
-0.01
3.22%
-0.90
9,733.22%
-0.43
52.57%
-0.13
68.91%
0.24
280.02%
-0.07
128.99%
0.00
100.07%
free cash flow yield
-0.00
-
-0.00
1.45%
-0.09
9,510.39%
-0.09
0.08%
-0.02
80.14%
0.03
246.71%
-0.03
199.59%
0.00
100.05%
graham net net
-0.16
-
-0.23
40.90%
-0.91
297.00%
-0.69
24.36%
-0.07
89.88%
-0.10
44.58%
-0.01
86.79%
-0.00
99.89%
graham number
0.59
-
1.86
212.28%
3.78
103.72%
2.42
35.89%
2.25
6.95%
5.60
148.48%
2.34
58.18%
0.00
99.90%
income quality
2.69
-
0.28
89.60%
0.94
234.42%
0.83
11.54%
0.38
54.28%
0.65
72.36%
1.60
145.07%
6.25
290.64%
intangibles to total assets
0
-
0
0
0.32
Infinity%
0.21
33.44%
0.20
3.94%
0.12
39.10%
0.11
10.21%
0.10
12.01%
interest coverage
-4.75
-
-3.27
31.07%
2.43
174.22%
10.08
314.59%
11.10
10.17%
-5.72
151.51%
interest debt per share
0.00
-
1.01
64,510.78%
1.18
16.71%
0.89
24.48%
1.09
21.97%
0.97
11.05%
0.00
99.96%
inventory turnover
5.17
-
3.31
35.84%
3.14
5.21%
4.56
45.30%
4.24
7.15%
3.77
11.06%
invested capital
-1.08K
-
0.00
-
1.26
375,335.99%
1.81
43.68%
0.58
67.94%
0.55
5.80%
0.47
14.76%
0.21
54.86%
market cap
616.16M
-
633.66M
2.84%
703.58M
11.04%
446.56M
36.53%
811.27M
81.67%
1.19B
46.16%
349.89M
70.49%
542.93B
155,073.28%
net current asset value
-290.37K
-
-9.89M
3,306.83%
-14.48M
46.42%
-45.51M
214.18%
-39.50M
13.19%
25.93M
165.65%
25.75M
0.69%
38.92M
51.11%
43.68M
12.24%
net debt to ebitda
4.98
-
0.01
99.89%
-0.93
16,585.27%
-2.02
117.37%
0.01
100.53%
0.21
1,803.12%
0.53
157.70%
-3.61
783.26%
net income per share
-0.00
-
-0.03
892.63%
-0.94
2,753.11%
-0.44
53.41%
0.17
138.23%
0.74
343.89%
0.12
83.85%
0.00
99.90%
operating cash flow per share
-0.01
-
-0.01
3.22%
-0.88
9,441.50%
-0.36
58.79%
0.06
117.48%
0.48
665.07%
0.19
60.43%
0.00
99.88%
payables turnover
3.59
-
2.68
25.48%
3.73
39.59%
3.89
4.22%
3.25
16.55%
3.47
6.69%
receivables turnover
5.68
-
6.63
16.80%
5.96
10.18%
5.68
4.69%
5.04
11.20%
5.28
4.79%
research and ddevelopement to revenue
0.06
-
0.06
2.12%
0.06
4.71%
0.07
10.62%
0.09
34.27%
0.10
16.19%
return on tangible assets
-0.00
-
-0.01
898.97%
-0.58
8,543.23%
-0.23
59.90%
0.08
132.90%
0.24
219.70%
0.04
84.08%
0.04
1.85%
revenue per share
2.79
-
2.81
0.73%
3.14
11.70%
3.65
16.16%
3.47
4.96%
0.00
99.91%
roe
-0.00
-
-0.01
910.37%
-1.38
19,514.79%
-0.73
47.19%
0.12
116.88%
0.39
219.12%
0.06
85.09%
0.06
2.78%
roic
0.00
-
-0.02
2,314.95%
-0.42
2,603.73%
-0.17
59.12%
0.11
163.60%
0.25
131.27%
0.04
84.59%
0.05
26.68%
sales general and administrative to revenue
shareholders equity per share
4.75
-
4.67
1.76%
0.68
85.45%
0.60
11.78%
1.36
126.48%
1.89
39.10%
2.04
8.30%
0.00
99.90%
stock based compensation to revenue
0.01
-
0.00
35.46%
0.00
36.90%
0.01
68.14%
0.01
76.02%
0.02
42.93%
tangible asset value
-162
-
300.11M
185,251,674.69%
298.01M
0.70%
-4.59M
101.54%
9.25M
301.50%
86.69M
837.49%
187.59M
116.39%
216.11M
15.20%
234.02M
8.29%
tangible book value per share
4.75
-
4.67
1.76%
-0.07
101.42%
0.10
250.45%
0.80
707.86%
1.46
81.67%
1.66
13.66%
0.00
99.89%
working capital
-290.37K
-
957.55K
429.77%
-3.63M
479.54%
4.74M
230.51%
65.71M
1,285.33%
106.13M
61.52%
144.97M
36.60%
147.59M
1.80%
144.53M
2.07%

All numbers in (except ratios and percentages)